N@N

CONN, CVGI, PSTI, NLY, NG, THLD Are Seasonally Ripe To Go Down In the Next Five Weeks

September 16, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of Conn's Inc. (NASDAQ:CONN), Commercial Vehicle Group Inc. (NASDAQ:CVGI), Pluristem Therapeutics Inc. (NASDAQ:PSTI), Annaly Capital Management Inc. (NYSE:NLY), NovaGold Resources, Inc. (NYSE:NG), Threshold Pharmaceuticals Inc. (NASDAQ:THLD) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  CONN    Conn's Inc.                      -4.92%           91.67% (11 of 12)    Thursday, September 22nd 2016
  CVGI    Commercial Vehicle Group Inc.    -7.41%           75.00% (9 of 12)     Thursday, September 22nd 2016
  PSTI    Pluristem Therapeutics Inc.      -7.93%           91.67% (11 of 12)    Friday, September 30th 2016
  NLY     Annaly Capital Management Inc.   -5.67%           88.89% (16 of 18)    Friday, October 7th 2016
  NG      NovaGold Resources, Inc.         -6.07%           75.00% (9 of 12)     Monday, September 26th 2016
  THLD    Threshold Pharmaceuticals Inc.   -6.01%           90.91% (10 of 11)    Wednesday, September 21st 2016

Conn's Inc. (NASDAQ:CONN) - Conn's, Inc. operates as a specialty retailer of durable consumer goods and related services in the United States. It operates through Retail and Credit segments. The company s stores provide home appliances comprising refrigerators, freezers, washers, dryers, dishwashers, and ranges; furniture and mattress, including furniture and related accessories for the living room, dining room, and bedroom, as well as traditional and specialty mattresses; and home office products consisting of computers, tablets, printers, and accessories. Its stores also offer consumer electronics, such as LED, OLED, Ultra HD, and Internet-ready televisions; and Blu-ray players, and home theater and portable audio equipment. Conn's, Inc. also provides repair service agreements, installment credit plans, and various credit insurance products. As of March 29, 2016, the company operated approximately 100 retail locations in Arizona, Colorado, Georgia, Louisiana, Mississippi, Nevada, New Mexico, North Carolina, Oklahoma, South Carolina, Tennessee, and Texas. Conn s, Inc. was founded in 1890 and is based in The Woodlands, Texas..

Commercial Vehicle Group Inc. (NASDAQ:CVGI) - Commercial Vehicle Group, Inc., together with its subsidiaries, designs, engineers, produces, and sells various cab related products and systems in North America, Europe, and the Asia/Pacific regions. It operates through two segments, the Global Truck and Bus, and the Global Construction and Agriculture. The Global Truck and Bus Segment provides seats and seating systems, including mechanical and air suspension seats, static seats, bus seats, and military seats, as well as seats for medium-and heavy-duty trucks; and aftermarket seats and components. It also offers trim systems and components for the interior cabs of commercial vehicles, such as vinyl or cloth-covered appliqu s, armrests, map pocket compartments, carpets, and sound-reducing insulations; instrument panels; headliners/wall panels; storage systems; floor covering systems; sleeper bunks; grab handles and armrests; privacy curtains; and plastics decorating and finishing products, as well as exterior components for commercial recreational and specialty vehicles. In addition, this segment provides cab structures, sleeper boxes, body panels, structural components, bumper fascias and fender liners; and mirrors, wipers, and controls. The Global Construction and Agriculture segment provides electronic wire harness assemblies that function as current carrying devices used to provide electrical interconnections for gauges, lights, control functions, power circuits, powertrain and transmission sensors, emissions systems, and other electronic applications on commercial vehicles; and panel assemblies and cabinets. The company supplies its products and systems for the commercial vehicle market, including the medium-and heavy-duty truck market; the medium-and heavy-construction vehicle market; and the military, bus, agriculture, specialty transportation, mining, industrial equipment, and off-road recreational markets. Commercial Vehicle Group, Inc. was founded in 2000 and is headquartered in New Albany, Ohio..

Pluristem Therapeutics Inc. (NASDAQ:PSTI) - Pluristem Therapeutics Inc., through its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. The company focuses on the research, development, clinical trials, and manufacture of cell therapeutics products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions. It develops placenta expanded (PLX) products, including PLX-PAD cells that are in Phase-II clinical trial for use in the treatment of peripheral and cardiovascular diseases, as well as for the treatment of orthopedic diseases. The company also develops PLX-R18 cells for hematopoietic cell transplantation in animals, as well as conducts various in-vivo studies for the evaluation of PLX-R18 for the treatment of ARS. It has commercialization agreement with CHA Biotech Co. Ltd. for conducting clinical trials PLX-PAD products in South Korea; and collaborative research agreement with the Berlin-Brandenburg Center for Regenerative Therapies. Pluristem Therapeutics Inc. was founded in 2001 and is based in Haifa, Israel..

Annaly Capital Management Inc. (NYSE:NLY) - Annaly Capital Management, Inc. owns a portfolio of real estate related investments in the United States. It invests in various types of agency mortgage-backed securities and related derivatives to hedge these investments; and residential credit investments, such as credit risk transfer securities and non-agency mortgage-backed securities. The company also acquires, finances, and manages commercial loans and other commercial real estate debt, commercial mortgage-backed securities, and other commercial real estate-related assets. In addition, it engages in corporate middle market lending transactions; and operates as a broker-dealer. The company has elected to be taxed as a real estate investment trust (REIT). As a REIT, it is not subject to federal income tax to the extent that it distributes its taxable income to its shareholders. Annaly Capital Management, Inc. was founded in 1997 and is based in New York, New York..

NovaGold Resources, Inc. (NYSE:NG) - NovaGold Resources Inc. explores and develops mineral properties in Canada and the United States. The company primarily explores for gold, silver, and copper deposits. It holds a 50% interest in the Donlin Gold property that covers an area of 71,420 acres located in the Kuskokwim region of southwestern Alaska; and a 50% interest in the Galore Creek property, a copper-gold-silver project covering an area of 293,837 acres in northwestern British Columbia. The company was formerly known as NovaCan Mining Resources (1985) Limited and changed its name to NovaGold Resources Inc. in March 1987. NovaGold Resources Inc. was founded in 1984 and is based in Vancouver, Canada..

Threshold Pharmaceuticals Inc. (NASDAQ:THLD) - Threshold Pharmaceuticals, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic agents that target tumor cells for the treatment of patients living with cancer in the United States. Its lead investigational small molecule is evofosfamide, which is in two Phase III clinical trials for the treatment of soft tissue sarcoma indication and advanced pancreatic cancer; Phase II clinical trials for treating non-squamous non-small cell lung cancer; Phase II clinical trials for advanced melanoma; and Phase I/II clinical trials for multiple myeloma. The company is also involved in the study of evofosfamide in investigator sponsored trials, including Phase I/II clinical trials for glioblastoma; Phase I clinical trials for advanced renal cell carcinoma, gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors; Phase II clinical trials for glioblastoma and pancreatic neuroendocrine tumors; Phase I clinical trials for advanced solid tumors; and Phase I/II clinical trials for advanced kidney cancer or liver cancer. In addition, it engages in developing Tarloxotinib, an investigational hypoxia-activated EGFR tyrosine kinase inhibitor, which is in two Phase II clinical trials for patients with advanced non-squamous non-small cell lung cancer, as well as patients with squamous cell carcinomas of the head, neck, or skin; and [18F]-HX4, an investigational PET imaging agent for hypoxia. The company has a license and co-development agreement with Merck KGaA to co-develop and commercialize evofosfamide; license agreement with Auckland UniServices Ltd. for the development program based on Tarloxotinib; and license agreement with Eleison Pharmaceuticals, Inc. for the manufacture, development, and commercialization of glufosfamide for the treatment of cancer in humans and animals, as well as other uses. Threshold Pharmaceuticals, Inc. was founded in 2001 and is headquartered in South San Francisco, California..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net